NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Cohort 1 and 2: High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
with FGFR Mutations or Fusions
Cohort 3 Intermediate Risk Non-Muscle-Invasive Bladder Cancer
(NMIBC) with FGFR Mutations or Fusions
1 total trials
Filter these 1 trials by phase, country, sponsor and more.